Skip to main content
Clinical Trials/CTRI/2023/01/049024
CTRI/2023/01/049024
Not yet recruiting
未知

Study of efficacy and patient satisfaction with subcutaneous vs intramuscular testosterone enanthate in hypogonadal male patients

Dr Nikhil Bhagwat0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Nikhil Bhagwat
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Nikhil Bhagwat

Eligibility Criteria

Inclusion Criteria

  • 1\.Adult hypogonadal men \>\=18 who are already on stable dose of Intramuscular Testosterone Enanthate therapy for more than 3 months duration

Exclusion Criteria

  • 1\.Coexistent Liver /Renal dysfunction
  • 2\.Congestive heart failure
  • 3\.History of following within the last 6 months of screening: Myocardial infarction (MI), unstable angina leading to hospitalization, percutaneous coronary intervention, coronary artery bypass graft, uncontrolled cardiac arrhythmia, stroke transient ischemia attack, carotid revascularization, endovascular procedure, or surgical intervention for peripheral vascular disease
  • 4\.Systemic infections
  • 5\.Positive serology for HIV, hepatitis B or hepatitis C
  • 6\.Skin conditions in injection site that could confound injection site assessments.
  • 7\.Use of other androgens (DHEA), anabolic steroids, other sex hormones) or other substances/supplements
  • 8\.History or current evidence of breast or prostate cancer
  • 9\.Elevated prostate\-specific antigen (PSA) for age
  • 10\.H/o psychiatric illnesses

Outcomes

Primary Outcomes

Not specified

Similar Trials